|
GTF2F2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.376400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.641800E-01 |
| Normal-vs-Stage2 |
7.234800E-01 |
| Normal-vs-Stage3 |
2.658600E-03 |
| Normal-vs-Stage4 |
5.302600E-01 |
| Stage1-vs-Stage2 |
8.723000E-01 |
| Stage1-vs-Stage3 |
5.985000E-04 |
| Stage1-vs-Stage4 |
4.813200E-01 |
| Stage2-vs-Stage3 |
3.007900E-02 |
| Stage2-vs-Stage4 |
4.672200E-01 |
| Stage3-vs-Stage4 |
1.743620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.936200E-01 |
| Normal-vs-AfricanAmerican |
2.252600E-01 |
| Normal-vs-Asian |
8.170600E-01 |
| Caucasian-vs-AfricanAmerican |
9.337800E-02 |
| Caucasian-vs-Asian |
8.999800E-01 |
| AfricanAmerican-vs-Asian |
2.482600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.850600E-01 |
| Normal-vs-Female |
3.030600E-01 |
| Male-vs-Female |
4.747600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.240200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.343200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.891600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.192500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.971600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.591800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.542400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.253400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.033800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.337010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.358200E-01 |
| Normal-vs-Grade 2 |
9.860000E-01 |
| Normal-vs-Grade 3 |
4.304000E-02 |
| Normal-vs-Grade 4 |
6.844400E-01 |
| Grade 1-vs-Grade 2 |
2.726600E-01 |
| Grade 1-vs-Grade 3 |
3.714300E-02 |
| Grade 1-vs-Grade 4 |
9.473600E-01 |
| Grade 2-vs-Grade 3 |
4.658300E-03 |
| Grade 2-vs-Grade 4 |
6.848200E-01 |
| Grade 3-vs-Grade 4 |
4.030600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.421400E-01 |
| Normal-vs-ccB subtype |
4.625600E-02 |
| ccA subtype-vs-ccB subtype |
2.097600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.879000E-01 |
| Normal-vs-N1 |
6.573000E-01 |
| N0-vs-N1 |
6.981000E-01 |
|
|
